Malgorzata Przybylska

1.2k total citations
16 papers, 1.0k citations indexed

About

Malgorzata Przybylska is a scholar working on Molecular Biology, Physiology and Clinical Biochemistry. According to data from OpenAlex, Malgorzata Przybylska has authored 16 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 4 papers in Physiology and 3 papers in Clinical Biochemistry. Recurrent topics in Malgorzata Przybylska's work include RNA Interference and Gene Delivery (5 papers), Metabolism and Genetic Disorders (3 papers) and Lysosomal Storage Disorders Research (3 papers). Malgorzata Przybylska is often cited by papers focused on RNA Interference and Gene Delivery (5 papers), Metabolism and Genetic Disorders (3 papers) and Lysosomal Storage Disorders Research (3 papers). Malgorzata Przybylska collaborates with scholars based in United States, South Korea and Netherlands. Malgorzata Przybylska's co-authors include Nelson S. Yew, Seng H. Cheng, I‐Huan Wu, Jennifer D. Tousignant, Hongmei Zhao, Ronald K. Scheule, Craig Siegel, Antonius Song, Hongmei Zhao and Jinhua Zhang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and PLoS ONE.

In The Last Decade

Malgorzata Przybylska

16 papers receiving 954 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Malgorzata Przybylska United States 13 760 325 195 157 102 16 1.0k
Carlos M. Farinha Portugal 25 702 0.9× 223 0.7× 136 0.7× 109 0.7× 87 0.9× 74 1.9k
Katsuya Inagaki Japan 10 761 1.0× 476 1.5× 76 0.4× 67 0.4× 64 0.6× 19 1.0k
Mark Whitmore United States 10 678 0.9× 231 0.7× 62 0.3× 532 3.4× 87 0.9× 15 1.2k
Babak Oskouian United States 19 1.1k 1.5× 91 0.3× 233 1.2× 111 0.7× 110 1.1× 26 1.3k
Maurizia Caruso Italy 20 1.1k 1.4× 258 0.8× 156 0.8× 85 0.5× 51 0.5× 30 1.4k
Angel Ashikov Germany 18 684 0.9× 110 0.3× 65 0.3× 167 1.1× 77 0.8× 30 945
T M Townes United States 16 1.6k 2.1× 756 2.3× 213 1.1× 85 0.5× 98 1.0× 18 2.1k
W. Held United States 20 833 1.1× 320 1.0× 81 0.4× 104 0.7× 114 1.1× 29 1.2k
Peter A. Bell United States 18 692 0.9× 219 0.7× 59 0.3× 94 0.6× 73 0.7× 32 1.0k
Patrick H. Thibodeau United States 19 823 1.1× 195 0.6× 67 0.3× 59 0.4× 61 0.6× 32 1.3k

Countries citing papers authored by Malgorzata Przybylska

Since Specialization
Citations

This map shows the geographic impact of Malgorzata Przybylska's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Malgorzata Przybylska with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Malgorzata Przybylska more than expected).

Fields of papers citing papers by Malgorzata Przybylska

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Malgorzata Przybylska. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Malgorzata Przybylska. The network helps show where Malgorzata Przybylska may publish in the future.

Co-authorship network of co-authors of Malgorzata Przybylska

This figure shows the co-authorship network connecting the top 25 collaborators of Malgorzata Przybylska. A scholar is included among the top collaborators of Malgorzata Przybylska based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Malgorzata Przybylska. Malgorzata Przybylska is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Belanger, Adam J., et al.. (2022). Excretion of excess nitrogen and increased survival by loss of SLC6A19 in a mouse model of ornithine transcarbamylase deficiency. Journal of Inherited Metabolic Disease. 46(1). 55–65. 5 indexed citations
2.
Przybylska, Malgorzata, Sarah Geller, Alla Kloss, et al.. (2018). Inhibiting neutral amino acid transport for the treatment of phenylketonuria. JCI Insight. 3(14). 35 indexed citations
3.
Ko, Ah‐Ra, Dong‐Kyu Jin, Sung Yoon Cho, et al.. (2016). AAV8-mediated expression of N-acetylglucosamine-1-phosphate transferase attenuates bone loss in a mouse model of mucolipidosis II. Molecular Genetics and Metabolism. 117(4). 447–455. 12 indexed citations
4.
Yew, Nelson S., Malgorzata Przybylska, David Reczek, et al.. (2013). Erythrocytes encapsulated with phenylalanine hydroxylase exhibit improved pharmacokinetics and lowered plasma phenylalanine levels in normal mice. Molecular Genetics and Metabolism. 109(4). 339–344. 21 indexed citations
5.
Yew, Nelson S., Hongmei Zhao, Eun‐Gyoung Hong, et al.. (2010). Increased Hepatic Insulin Action in Diet-Induced Obese Mice Following Inhibition of Glucosylceramide Synthase. PLoS ONE. 5(6). e11239–e11239. 28 indexed citations
6.
Zhao, Hongmei, Malgorzata Przybylska, Jinhua Zhang, et al.. (2009). Inhibiting glycosphingolipid synthesis ameliorates hepatic steatosis in obese mice #. Hepatology. 50(1). 85–93. 77 indexed citations
7.
Zhao, Hongmei, Malgorzata Przybylska, Jinhua Zhang, et al.. (2007). Inhibiting Glycosphingolipid Synthesis Improves Glycemic Control and Insulin Sensitivity in Animal Models of Type 2 Diabetes. Diabetes. 56(5). 1210–1218. 200 indexed citations
9.
Przybylska, Malgorzata, I‐Huan Wu, Hongmei Zhao, et al.. (2003). Partial correction of the α‐galactosidase A deficiency and reduction of glycolipid storage in Fabry mice using synthetic vectors. The Journal of Gene Medicine. 6(1). 85–92. 23 indexed citations
10.
Yew, Nelson S., Hongmei Zhao, Malgorzata Przybylska, et al.. (2002). CpG-Depleted Plasmid DNA Vectors with Enhanced Safety and Long-Term Gene Expression in Vivo. Molecular Therapy. 5(6). 731–738. 181 indexed citations
11.
Yew, Nelson S., Hongmei Zhao, I‐Huan Wu, et al.. (2000). Reduced Inflammatory Response to Plasmid DNA Vectors by Elimination and Inhibition of Immunostimulatory CpG Motifs. Molecular Therapy. 1(3). 255–262. 182 indexed citations
12.
Yew, Nelson S., Malgorzata Przybylska, Rebecca G. Bagley, et al.. (1999). Contribution of Plasmid DNA to Inflammation in the Lung after Administration of Cationic Lipid:pDNA Complexes. Human Gene Therapy. 10(2). 223–234. 158 indexed citations
13.
Rosenberg, Michael A., et al.. (1998). Positional cloning without a genome map: Using 'Targeted RFLP Subtraction' to isolate dense markers tightly linked to the regA locus of Volvox carteri. Nucleic Acids Research. 26(7). 1812–1818. 6 indexed citations
14.
Choi, Giltsu, Malgorzata Przybylska, & Daniel A. Straus. (1996). Three abundant germ line-specific transcripts in Volvox carteri encode photosynthetic proteins. Current Genetics. 30(4). 347–355. 22 indexed citations
15.
Rosenberg, Michael A., Malgorzata Przybylska, & Daniel A. Straus. (1994). "RFLP subtraction": a method for making libraries of polymorphic markers.. Proceedings of the National Academy of Sciences. 91(13). 6113–6117. 34 indexed citations
16.
Konieczny, Andrzej, et al.. (1988). Expression of lupin nodulin genes during root nodule development. Plant Science. 55(2). 145–149. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026